Restoration of frontal activation during a treatment with quetiapine: An fMRI study of blunted affect in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 1, 2005, Pages 21-26

  Stip, Emmanuel ^a   Fahim, Cherine ^a,c   Mancini Marïe, Adham ^a   Bentaleb, Lahcen Ait ^a   Mensour, Boualem ^b   Mendrek, Adrianna ^a   Beauregard, Mario ^c  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blunted affect; Emotions; fMRI; Negative symptoms; Prefrontal cortex; Quetiapine; Schizophrenia

Indexed keywords

QUETIAPINE;

ADULT; AFFECT; ARTICLE; AUDIOVISUAL EQUIPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; FRONTAL CORTEX; HUMAN; MALE; MEDULLA OBLONGATA; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; RATING SCALE; SCHIZOPHRENIA;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; ECHO-PLANAR IMAGING; EMOTIONS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 10944242712     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.08.015     Document Type: Article

References (32)

1. R. Abrams, and M.A. Taylor A rating scale for emotional blunting Am. J. Psychiatry 135 1978 226 229
2. D. Addington, J. Addington, and E. Maticka-Tyndale Assessing depression in schizophrenia: the Calgary Depression Scale Br. J. Psychiatr., Suppl. 22 1993 39 44
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Press Washington, DC
4. R. Bandler, K.A. Keay, N. Floyd, and J. Price Central circuits mediating patterned autonomic activity during active vs. passive emotional coping Brain Res. Bull. 53 1 2000 95 104
5. M.D. Bell, P.H. Lysaker, J.L. Beam-Goulet, R.M. Milstein, and J.P. Lindenmayer Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale Psychiatry Res. 52 3 1994 295 303 (Jun.)
6. H. Berenbaum, and T.F. Oltmanns Emotional experience and expression in schizophrenia and depression J. Abnorm. Psychology 101 1 1992 37 44
7. J.F. Bernard, and R. Bandler Parallel circuits for emotional coping behaviour: new pieces in the puzzle J. Comp. Neurol. 401 4 1998 429 436
8. R.W. Buchanan, and W.T. Carpenter Evaluating negative symptom treatment efficacy R.S. Keefe J.P. McEvoy Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia 2001 American Psychiatric Press Washington 1 18
9. C. Fahim, E. Stip, L.A. Bentaleb, M. Boualem, J.M. Leroux, and M. Beauregard Cerebral activity associated with expression of blunted affect in schizophrenia Schizophr. Res. 53 3 2002 111
10. C. Fahim, E. Stip, J.M. Leroux, M. Boualem, and G. Beaudoin Cerebral mechanisms involved in implicit emotional processing in schizophrenia patients without blunted affect and normal controls: a functional magnetic resonance imaging approach Brain Cogn. 51 2003 193 195
11. K.J. Friston, and R.S.J. Frackowiak Images of the future: a philosophical coda R.S.J. Frackowiak K.J. Friston R.J. Dolan J.C. Mazziotta Human Brain Function 1997 Academic Press San Diego 487 517
12. R.E. Gur, C. McGrath, R.M. Chan, L. Schroeder, T. Turner, B.I. Turetsky, C. Kohler, D. Alsop, J. Maldjian, J.D. Ragland, and R.C. Gur An fMRI study of facial emotion processing in patients with schizophrenia Am. J. Psychiatry 159 12 2002 1992 1999
13. C. Heimberg, R.E. Gur, R.J. Erwin, D.L. Shtasel, and R.C. Gur Facial emotion discrimination: III. Behavioral findings in schizophrenia Psychiatry Res. 42 3 1992 253 265
14. J. Ichikawa, and H.Y. Meltzer Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 90 98
15. S. Kapur, R. Zipursky, C. Jones, C.M. Shammi, G. Remington, and P. Seeman A positron emission tomography study of quetiapine in schizophrenia Arch. Gen. Psychiatry 57 2000 553 559
16. S. Kasper, J. Tauscher, and A. Heiden Quetiapine: efficacy and tolerability in schizophrenia Eur. Neuropsychopharmacol. 11 Suppl. 4 2001 S405 S413
17. S.R. Kay, A. Fiszbein, and L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
18. C.G. Kohler, T.H. Turner, W.B. Bilker, C.M. Brensinger, S.J. Siegel, S.J. Kanes, R.E. Gur, and R.C. Gur Facial emotion recognition in schizophrenia: intensity effects and error pattern Am. J. Psychiatry 160 10 2003 1768 1774
19. R. Krause, E. Steimer, C. Sanger-Alt, and G. Wagner Facial expression of schizophrenic patients and their interaction partners Psychiatry 52 1 1989 1 12
20. J. Levesque, F. Eugene, Y. Joanette, V. Paquette, B. Mensour, G. Beaudoin, J.M. Leroux, P. Bourgouin, and M. Beauregard Neural circuitry underlying voluntary suppression of sadness Biol. Psychiatry 53 6 2003 502 510
21. R.M. Mattes, F. Schneider, H. Heimann, and N. Birbaumer Reduced emotional response of schizophrenic patients in remission during social interaction Schizophr. Res. 17 3 1995 249 255
22. H.Y. Meltzer, S. Matsubara, and J.C. Lee The ratios of serotonin2 and dopamine2 affinities differentiate atypical antipsychotic drugs Psychopharmacol. Bull. 25 1989 390 392
23. S. Paradiso, N.C. Andreasen, B. Crespo-Facorro, D.S. O'Leary, G.L. Watkins, L.L. Boles Ponto, and R.D. Hichwa Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography Am. J. Psychiatry 160 10 2003 1775 1783
24. K.L. Phan, T. Wager, S.F. Taylor, and I. Liberzon Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI Neuroimage 16 2002 331 348
25. M.L. Phillips Understanding the neurobiology of emotion perception: implications for psychiatry Br. J. Psychiatry 182 2003 190 192
26. M.F. Pogue-Geile, and M. Harrow Negative symptoms in schizophrenia: their longitudinal course and prognostic importance Schizophr. Bull. 11 1985 427 439
27. P. Seeman, and T. Tallerico Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors Mol. Psychiatry 3 2 1998 123 134
28. S.M. Stahl Essential Psychopharmacology of Antipsychotics and Mood Stabilizers 2nd ed. 2002 Cambridge University Press Cambridge 59 75
29. E. Stip, I. Lussier, M. Babai, J.L. Fabian, and C. Link Seroquel and cognitive improvement in patients with schizophrenia Biol. Psychiatry 40 5 1996 434 435
30. L. Sweet, M. Primeau, C. Fichtner, and G. Lutz Dissociation of affect recognition and mood state from blunting in patients with schizophrenia Psychiatry Res. 81 1998 301 308
31. J. Talairach, and P. Tournoux Co-Planar Stereotaxic Atlas of the Human Brain 1988 Thieme Medical Stuttgart
32. R. Tandon Improvement without impairment: a review of clinical data for quetiapine in the treatment of schizophrenia J. Clin. Psychopharmacol. 23 3 Suppl. 1 2003 S15 S20